{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:53:06Z","timestamp":1790837586165,"version":"4.1.0"},"reference-count":248,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00724","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T14:33:42Z","timestamp":1561991622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":160,"title":["Gene Therapy Tools for Brain Diseases"],"prefix":"10.3389","volume":"10","author":[{"given":"Selene","family":"Ingusci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Verlengia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Soukupova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Simonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jgm.566","article-title":"Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness","volume":"6","author":"Agha-Mohammadi","year":"2004","journal-title":"J. Gene. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21775\/cimb.028.047","article-title":"A review of CRISPR-based genome editing: survival, evolution and challenges","volume":"28","author":"Ahmad","year":"2018","journal-title":"Curr. Issues Mol. Biol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1128\/JVI.71.8.5871-5877.1997","article-title":"Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A","volume":"71","author":"Aiken","year":"1997","journal-title":"J. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuron.2009.06.014","article-title":"Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors","volume":"63","author":"Alexander","year":"2009","journal-title":"Neuron"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6030074","article-title":"Herpes simplex virus vectors for gene transfer to the central nervous system","volume":"6","author":"Artusi","year":"2018","journal-title":"Diseases"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1523\/JNEUROSCI.22-23-10302.2002","article-title":"Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson\u2019s disease","volume":"22","author":"Azzouz","year":"2002","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jocn.2008.10.001","article-title":"Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy\u2014Part 2","volume":"16","author":"Badawy","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chembiol.2005.10.017","article-title":"Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity","volume":"13","author":"Bayle","year":"2006","journal-title":"Chem. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0092-8674(00)81967-4","article-title":"The protein CTCF is required for the enhancer blocking activity of vertebrate insulators","volume":"98","author":"Bell","year":"1999","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1172\/JCI57367","article-title":"The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice","volume":"121","author":"Bell","year":"2011","journal-title":"J. Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1089\/10430349950016393","article-title":"Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington\u2019s disease, as demonstrated by adenoviral gene transfer","volume":"10","author":"Bemelmans","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.mt.6300018","article-title":"Transduction of brain by herpes simplex virus vectors","volume":"15","author":"Berges","year":"2007","journal-title":"Mol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-80207-2_1","article-title":"Biology of adeno-associated virus","volume":"218","author":"Berns","year":"1996","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0960-9822(98)70198-8","article-title":"Design of allele-specific inhibitors to probe protein kinase signaling","volume":"8","author":"Bishop","year":"1998","journal-title":"Curr. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbagrm.2009.12.001","article-title":"Epigenetic regulation of latent HSV-1 gene expression","volume":"1799","author":"Bloom","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6414","article-title":"Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques","volume":"10","author":"Borel","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/bjp.2008.349","article-title":"Viral vectors: from virology to transgene expression","volume":"157","author":"Bouard","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00050","article-title":"Systemic gene delivery to the central nervous system using Adeno-associated virus","volume":"7","author":"Bourdenx","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/156652307780859062","article-title":"Current advances and future challenges in Adenoviral vector biology and targeting","volume":"7","author":"Campos","year":"2007","journal-title":"Curr. Gene. Ther."},{"key":"B25","volume-title":"Guide to research techniques in neuroscience","author":"Carter","year":"2015"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1073\/pnas.96.6.2988","article-title":"Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors","volume":"96","author":"Case","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jmv.21045","article-title":"A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005","volume":"80","author":"Chang","year":"2008","journal-title":"J. Med. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.expneurol.2014.06.022","article-title":"Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism","volume":"261","author":"Chen","year":"2014","journal-title":"Exp. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.2025","article-title":"Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy","volume":"15","author":"Chen","year":"2009","journal-title":"Nat. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"30675","DOI":"10.18632\/oncotarget.5169","article-title":"Progresses towards safe and efficient gene therapy vectors","volume":"6","author":"Chira","year":"2015","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/exnr.1998.6887","article-title":"Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor","volume":"154","author":"Choi-Lundberg","year":"1998","journal-title":"Exp. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/mt.2015.231","article-title":"Widespread central nervous system gene transfer and silencing after systemic delivery of novel AAV-AS vector","volume":"24","author":"Choudhury","year":"2016","journal-title":"Mol. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature08652","article-title":"High-performance genetically targetable optical neural silencing by light-driven proton pumps","volume":"463","author":"Chow","year":"2010","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-2478(97)00049-7","article-title":"Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response","volume":"57","author":"Christ","year":"1997","journal-title":"Immunol. Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e3181c29356","article-title":"Safety and tolerability of putaminal AADC gene therapy for Parkinson disease","volume":"73","author":"Christine","year":"2009","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0092-8674(93)80052-G","article-title":"A 5\u2019 element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila","volume":"74","author":"Chung","year":"1993","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science1108367","article-title":"Structural bioinformatics-based design of selective, irreversible kinase inhibitors","volume":"308","author":"Cohen","year":"2005","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/B978-0-12-386509-0.00003-X","article-title":"Retrovirus and lentivirus vector design and methods of cell conditioning","volume":"507","author":"Cooray","year":"2012","journal-title":"Methods Enzymol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1073\/pnas.95.1.352","article-title":"Controlling signaling with a specifically designed G(i)-coupled receptor","volume":"95","author":"Coward","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/scientificamerican0979-219","article-title":"Thinking about the brain","volume":"241","author":"Crick","year":"1979","journal-title":"Sci. Am."},{"key":"B43","first-page":"495","article-title":"Human gene therapy: novel approaches to improve the current gene delivery systems","volume":"21","author":"Cucchiarini","year":"2016","journal-title":"Discov. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1517\/14712598.7.7.975","article-title":"HSV-1 amplicon vectors: a promising and versatile tool for gene delivery","volume":"7","author":"Cuchet","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature11127","article-title":"Chemical genetic discovery of targets and anti-targets for cancer polypharmacology","volume":"486","author":"Dar","year":"2012","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"18776","DOI":"10.1074\/jbc.M313895200","article-title":"Viral evolution as a tool to improve the tetracycline-regulated gene expression system","volume":"279","author":"Das","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.050581197","article-title":"Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system","volume":"97","author":"Davidson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005707","article-title":"Altering neuronal excitability to preserve network connectivity in a computational model of Alzheimer\u2019s disease","volume":"13","author":"de Haan","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nmeth.f.324","article-title":"Optogenetics","volume":"8","author":"Deisseroth","year":"2011","journal-title":"Nat. Methods"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nn.4091","article-title":"Optogenetics: 10 years of microbial opsins in neuroscience","volume":"18","author":"Deisseroth","year":"2015","journal-title":"Nat. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-3-662-05599-1_9","article-title":"Replicating adenoviruses in cancer therapy","volume":"273","author":"Dobbelstein","year":"2004","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coviro.2016.07.006","article-title":"Systemic delivery of adeno-associated viral vectors","volume":"21","author":"Duan","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"B56","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","article-title":"Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue","volume":"72","author":"Duan","year":"1998","journal-title":"J. Virol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1006\/mthe.2001.0456","article-title":"Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison","volume":"4","author":"Duan","year":"2001","journal-title":"Mol. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.addr.2005.09.017","article-title":"Dendrimers in gene delivery","volume":"57","author":"Dufes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s13205-013-0189-2","article-title":"Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003","volume":"4","author":"Dutta","year":"2014","journal-title":"3 Biotech"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","article-title":"Results from a phase I safety trial of hAADC gene therapy for Parkinson disease","volume":"70","author":"Eberling","year":"2008","journal-title":"Neurology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.08.024","article-title":"A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo","volume":"191","author":"Ebert","year":"2005","journal-title":"Exp. Neurol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/hum.2010.233","article-title":"The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors","volume":"22","author":"Emery","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1590\/S0074-02762009000300002","article-title":"HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties - A review","volume":"104","author":"Epstein","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/gt.2009.42","article-title":"Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors","volume":"16","author":"Epstein","year":"2009","journal-title":"Gene Ther."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150995","article-title":"Silencing status epilepticus-induced BDNF expression with herpes simplex virus type-1 based amplicon vectors","volume":"11","author":"Falcicchia","year":"2016","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a023754","article-title":"Genome-editing technologies: principles and applications","volume":"8","author":"Gaj","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B68","article-title":"Vectors and delivery systems in gene therapy","volume":"11","author":"Gardlik","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"B69","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrg1925","article-title":"Insulators: exploiting transcriptional and epigenetic mechanisms","volume":"7","author":"Gaszner","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1089\/hum.2004.15.934","article-title":"Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector","volume":"15","author":"Georgievska","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/sj.mt.6300322","article-title":"A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner","volume":"16","author":"Ghosh","year":"2008","journal-title":"Mol. Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.3390\/ijms140816010","article-title":"Non-coding RNAs: multi-tasking molecules in the cell","volume":"14","author":"Gomes","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1126\/science.7792603","article-title":"Transcriptional activation by tetracyclines in mammalian cells","volume":"268","author":"Gossen","year":"1995","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ymthe.2005.03.022","article-title":"Regulatable gene expression systems for gene therapy applications: progress and future challenges","volume":"12","author":"Goverdhana","year":"2005","journal-title":"Mol. Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"J. Virol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jgm.1122","article-title":"Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors","volume":"10","author":"Gruh","year":"2008","journal-title":"J. Gene. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nn.2495","article-title":"Ultrafast optogenetic control","volume":"13","author":"Gunaydin","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027728","article-title":"Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system","volume":"6","author":"Hadaczek","year":"2011","journal-title":"PLoS One"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188830","article-title":"Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS One"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00536-18","article-title":"Cellular antisilencing elements support transgene expression from herpes simplex virus vectors in the absence of immediate early gene expression","volume":"92","author":"Han","year":"2018","journal-title":"J. Virol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1089\/hum.1996.7.10-1205","article-title":"An improved plasmid DNA expression vector for direct injection into skeletal muscle","volume":"7","author":"Hartikka","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-2-210","article-title":"The Argonaute protein family","volume":"9","author":"Hock","year":"2008","journal-title":"Genome Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.ymthe.2003.09.011","article-title":"Deoxyribonuclease II is a lysosomal barrier to transfection","volume":"8","author":"Howell","year":"2003","journal-title":"Mol. Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1096\/fj.06-7380com","article-title":"Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"21","author":"Huang","year":"2007","journal-title":"FASEB J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1128\/JVI.74.10.4765-4775.2000","article-title":"Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant","volume":"74","author":"Ikeda","year":"2000","journal-title":"J. Virol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2ra4","DOI":"10.1126\/scitranslmed.3000130","article-title":"Dopamine gene therapy for Parkinson\u2019s disease in a nonhuman primate without associated dyskinesia","volume":"1","author":"Jarraya","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1080\/17425247.2016.1188802","article-title":"Current status of non-viral gene therapy for CNS disorders","volume":"13","author":"Jayant","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1128\/JVI.75.15.6884-6893.2001","article-title":"Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity","volume":"75","author":"Kaludov","year":"2001","journal-title":"J. Virol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000123041","article-title":"FKBP family proteins: immunophilins with versatile biological functions","volume":"16","author":"Kang","year":"2008","journal-title":"Neurosignals"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1073\/pnas.1606171113","article-title":"PPARgamma-coactivator-1alpha gene transfer reduces neuronal loss and amyloid-beta generation by reducing beta-secretase in an Alzheimer\u2019s disease model","volume":"113","author":"Katsouri","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4847","article-title":"Chemical-genetic attenuation of focal neocortical seizures","volume":"5","author":"Katzel","year":"2014","journal-title":"Nat. Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"12744","DOI":"10.1073\/pnas.94.24.12744","article-title":"Gene therapy","volume":"94","author":"Kay","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B98","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/156652311796150363","article-title":"Advances and future challenges in adenoviral vector pharmacology and targeting","volume":"11","author":"Khare","year":"2011","journal-title":"Curr. Gene. Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/B978-0-12-386509-0.00017-X","article-title":"Regulatory structures for gene therapy medicinal products in the European Union","volume":"507","author":"Klug","year":"2012","journal-title":"Methods Enzymol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1021\/bc060327a","article-title":"An acetal-based PEGylation reagent for pH-Sensitive shielding of DNA polyplexes","volume":"18","author":"Knorr","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/hum.2017.095","article-title":"Dual AAV gene therapy for duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the canine model","volume":"29","author":"Kodippili","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B102","doi-asserted-by":"publisher","first-page":"609","DOI":"10.15252\/emmm.201506078","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"Korbelin","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B103","first-page":"238","article-title":"An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger","volume-title":"Nature","author":"Krashes","year":"2014"},{"key":"B104","doi-asserted-by":"publisher","first-page":"U622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the Huntington\u2019s disease mutation","volume":"330","author":"Kremer","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/sj.gt.3300766","article-title":"Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons","volume":"5","author":"Krisky","year":"1998","journal-title":"Gene Ther."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/ncomms2376","article-title":"On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy","volume":"4","author":"Krook-Magnuson","year":"2013","journal-title":"Nat. Commun."},{"key":"B108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.gt.3301905","article-title":"Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area","volume":"10","author":"Kugler","year":"2003","journal-title":"Gene Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/mcne.2000.0929","article-title":"Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors","volume":"17","author":"Kugler","year":"2001","journal-title":"Mol. Cell Neurosci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.0959-9673.2004.00383.x","article-title":"Herpes simplex virus-based vectors","volume":"85","author":"Lachmann","year":"2004","journal-title":"Int. J. Exp. Pathol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1099\/0022-1317-77-10-2575","article-title":"A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection","volume":"77","author":"Lachmann","year":"1996","journal-title":"J. Gen. Virol."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102538","article-title":"Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates","volume":"9","author":"Le Guiner","year":"2014","journal-title":"PLoS One"},{"key":"B113","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/glia.20622","article-title":"GFAP promoter elements required for region-specific and astrocyte-specific expression","volume":"56","author":"Lee","year":"2008","journal-title":"Glia"},{"key":"B115","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jgm.694","article-title":"Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer","volume":"7","author":"Lee","year":"2005","journal-title":"J. Gene Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"E4264","DOI":"10.1073\/pnas.1716900115","article-title":"Polysialic acid is a cellular receptor for human adenovirus 52","volume":"115","author":"Lenman","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","article-title":"Gene therapy progress and prospects: non-viral gene therapy by systemic delivery","volume":"13","author":"Li","year":"2006","journal-title":"Gene Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/cr.2008.1","article-title":"Homologous recombination in DNA repair and DNA damage tolerance","volume":"18","author":"Li","year":"2008","journal-title":"Cell Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1364\/BOE.6.004859","article-title":"OptogenSIM: a 3D Monte Carlo simulation platform for light delivery design in optogenetics","volume":"6","author":"Liu","year":"2015","journal-title":"Biomed. Opt. Express"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"B122","first-page":"359","article-title":"Progress and challenges in viral vector-mediated gene transfer to the brain","volume":"4","author":"Lowenstein","year":"2002","journal-title":"Curr. Opin. Mol. Ther."},{"key":"B123","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.gt.3302048","article-title":"Inflammation and adaptive immune responses to adenoviral vectors injected into the brain: peculiarities, mechanisms, and consequences","volume":"10","author":"Lowenstein","year":"2003","journal-title":"Gene Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.coph.2003.10.005","article-title":"Recent advances in the pharmacology of neurological gene therapy","volume":"4","author":"Lowenstein","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple vectors expand AAV transfer capacity in the retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol. Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1206606","article-title":"Chemical and genetic engineering of selective ion channel\u2013ligand interactions","volume":"333","author":"Magnus","year":"2011","journal-title":"Science"},{"key":"B127","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ymthe.2005.11.009","article-title":"Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders","volume":"13","author":"Mandel","year":"2006","journal-title":"Mol. Ther."},{"key":"B128","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/hum.1993.4.4-419","article-title":"Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice","volume":"4","author":"Manthorpe","year":"1993","journal-title":"Hum. Gene Ther."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12896-015-0230-0","article-title":"Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in vivo","volume":"16","author":"Mao","year":"2016","journal-title":"BMC Biotechnol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/sj.gt.3300882","article-title":"Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo","volume":"6","author":"Marconi","year":"1999","journal-title":"Gene Ther."},{"key":"B131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0378-1119(88)90103-5","article-title":"A comparison of bovine growth-hormone gene expression in mouse L cells directed by the Moloney murine-leukemia virus long terminal repeat, simian virus-40 early promoter or cytomegalovirus immediate-early promoter","volume":"70","author":"Martin-Gallardo","year":"1988","journal-title":"Gene"},{"key":"B132","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jgm.1338","article-title":"Intranuclear fluorescence resonance energy transfer analysis of plasmid DNA decondensation from nonviral gene carriers","volume":"11","author":"Matsumoto","year":"2009","journal-title":"J. Gene. Med."},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1182\/blood.V99.7.2342","article-title":"Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide","volume":"99","author":"Maurice","year":"2002","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2014.05.044","article-title":"Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection","volume":"576","author":"McLean","year":"2014","journal-title":"Neurosci. Lett."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1038\/mtna.2016.7","article-title":"Design, characterization, and lead selection of therapeutic miRNAs targeting Huntingtin for development of gene therapy for Huntington\u2019s disease","volume":"5","author":"Miniarikova","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B139","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/hum.2011.220","article-title":"Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson\u2019s disease","volume":"23","author":"Mittermeyer","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1423556112","article-title":"Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity","volume":"112","author":"Miyagawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B141","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.omtm.2017.06.001","article-title":"Deletion of the virion host shut-off gene enhances neuronal-selective transgene expression from an HSV vector lacking functional IE genes","volume":"6","author":"Miyagawa","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B142","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1472-6750-10-92","article-title":"Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange","volume":"10","author":"Morris","year":"2010","journal-title":"BMC Biotechnol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"12792","DOI":"10.1128\/JVI.76.24.12792-12802.2002","article-title":"A cis-acting element that directs circular adeno-associated virus replication and packaging","volume":"76","author":"Musatov","year":"2002","journal-title":"J. Virol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"13940","DOI":"10.1073\/pnas.1936192100","article-title":"Channelrhodopsin-2, a directly light-gated cation-selective membrane channel","volume":"100","author":"Nagel","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/595410","article-title":"Gene regulation systems for gene therapy applications in the central nervous system","volume":"2012","author":"Naidoo","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"B146","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J. Virol."},{"key":"B147","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1128\/JVI.73.7.5438-5447.1999","article-title":"Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver","volume":"73","author":"Nakai","year":"1999","journal-title":"J. Virol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"B149","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"B150","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/jnr.490260317","article-title":"Gene transfer into brain tumor cell lines: reporter gene expression using various cellular and viral promoters","volume":"26","author":"Oellig","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/newbio233149a0","article-title":"Rhodopsin-like protein from the purple membrane of Halobacterium halobium","volume":"233","author":"Oesterhelt","year":"1971","journal-title":"Nat. New Biol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.gt.3300900","article-title":"PEGylated DNA\/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery","volume":"6","author":"Ogris","year":"1999","journal-title":"Gene Ther."},{"key":"B153","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1128\/MCB.8.1.457","article-title":"Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells","volume":"8","author":"Palella","year":"1988","journal-title":"Mol. Cell Biol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/humc.2018.081","article-title":"Long-term follow-up of a phase I\/II study of ProSavin, a lentiviral vector gene therapy for Parkinson\u2019s disease","volume":"29","author":"Palfi","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","article-title":"Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial","volume":"383","author":"Palfi","year":"2014","journal-title":"Lancet"},{"key":"B156","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0378-1119(85)90221-5","article-title":"Growth hormone gene expression in eukaryotic cells directed by the Rous sarcoma virus long terminal repeat or cytomegalovirus immediate-early promoter","volume":"38","author":"Pasleau","year":"1985","journal-title":"Gene"},{"key":"B157","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1086\/426545","article-title":"Nonantimicrobial effects of antibacterial agents","volume":"40","author":"Pasquale","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1089\/hum.1996.7.16-2003","article-title":"A novel \u2018piggyback\u2019 packaging system for herpes simplex virus amplicon vectors","volume":"7","author":"Pechan","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"B159","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/sj.gt.3300358","article-title":"Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters","volume":"4","author":"Peel","year":"1997","journal-title":"Gene Ther."},{"key":"B160","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.omtm.2018.01.002","article-title":"Pharmacology of recombinant adeno-associated virus production","volume":"8","author":"Penaud-Budloo","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s11095-010-0364-7","article-title":"Barriers to non-viral vector-mediated gene delivery in the nervous system","volume":"28","author":"Perez-Martinez","year":"2011","journal-title":"Pharm. Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1261\/rna5160904","article-title":"Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs)","volume":"10","author":"Persengiev","year":"2004","journal-title":"RNA"},{"key":"B163","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.omtn.2017.04.011","article-title":"Safe and efficient silencing with a Pol II, but not a Pol lII, promoter expressing an artificial miRNA targeting human Huntingtin","volume":"7","author":"Pfister","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B164","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1089\/hum.2017.199","article-title":"Artificial miRNAs reduce human mutant Huntingtin throughout the striatum in a transgenic sheep model of Huntington\u2019s disease","volume":"29","author":"Pfister","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2009.06.001","article-title":"CTCF: master weaver of the genome","volume":"137","author":"Phillips","year":"2009","journal-title":"Cell"},{"key":"B166","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-015-0044-5","article-title":"Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson\u2019s disease","volume":"10","author":"Pienaar","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"B167","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1016\/j.jconrel.2008.09.047","article-title":"Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: structure effects and in vitro gene transfer properties","volume":"132","author":"Piest","year":"2008","journal-title":"J. Control. Release"},{"key":"B168","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jgm.712","article-title":"Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters","volume":"7","author":"Pluta","year":"2005","journal-title":"J. Gene Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2217\/fnl-2017-0035","article-title":"New directions in therapeutics for Huntington disease","volume":"13","author":"Potkin","year":"2018","journal-title":"Future Neurol."},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010611","article-title":"Systematic comparison of constitutive promoters and the doxycycline-inducible promoter","volume":"5","author":"Qin","year":"2010","journal-title":"PLoS One"},{"key":"B171","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrg2765","article-title":"Insulators and promoters: closer than we think","volume":"11","author":"Raab","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"B172","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease","volume":"10","author":"Rafii","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/10443.5394","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"B174","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2007.01.125","article-title":"Glutamatergic or GABAergic neuron-specific, long-term expression in neocortical neurons from helper virus-free HSV-1 vectors containing the phosphate-activated glutaminase, vesicular glutamate transporter-1, or glutamic acid decarboxylase promoter","volume":"1144","author":"Rasmussen","year":"2007","journal-title":"Brain Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2217\/14796694.2.1.137","article-title":"Current developments in adenovirus-based cancer gene therapy","volume":"2","author":"Rein","year":"2006","journal-title":"Future Oncol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1385\/MN:28:3:259","article-title":"Wild-type huntingtin plays a role in brain development and neuronal survival","volume":"28","author":"Reiner","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00063030-200216010-00001","article-title":"Improvements in gene therapy: averting the immune response to adenoviral vectors","volume":"16","author":"Ritter","year":"2002","journal-title":"BioDrugs"},{"key":"B179","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1128\/JVI.74.10.4679-4687.2000","article-title":"The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites","volume":"74","author":"Rivella","year":"2000","journal-title":"J. Virol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm0996-1028","article-title":"A humanized system for pharmacologic control of gene expression","volume":"2","author":"Rivera","year":"1996","journal-title":"Nat. Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington\u2019s disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2016.26","article-title":"Microglia-specific targeting by novel capsid-modified AAV6 vectors","volume":"3","author":"Rosario","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B183","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/BJ20120146","article-title":"Lentiviral vectors: basic to translational","volume":"443","author":"Sakuma","year":"2012","journal-title":"Biochem. J."},{"key":"B184","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1128\/JVI.71.6.4614-4625.1997","article-title":"The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27","volume":"71","author":"Samaniego","year":"1997","journal-title":"J. Virol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ymthe.2005.06.480","article-title":"Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats","volume":"13","author":"Sanftner","year":"2006","journal-title":"Mol. Ther."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1073\/pnas.0308698100","article-title":"Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells","volume":"101","author":"Scacheri","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1523\/JNEUROSCI.3277-14.2015","article-title":"Patterned, but not tonic, optogenetic stimulation in motor thalamus improves reaching in acute drug-induced Parkinsonian rats","volume":"35","author":"Seeger-Armbruster","year":"2015","journal-title":"J. Neurosci."},{"key":"B188","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/157488509788185123","article-title":"Adenoviral vector-based strategies for cancer therapy","volume":"4","author":"Sharma","year":"2009","journal-title":"Curr. Drug Ther."},{"key":"B189","doi-asserted-by":"publisher","first-page":"13532","DOI":"10.1074\/jbc.M110.210922","article-title":"Terminal N-linked galactose is the primary receptor for adeno-associated virus 9","volume":"286","author":"Shen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1128\/JVI.65.2.787-795.1991","article-title":"A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties","volume":"65","author":"Shepard","year":"1991","journal-title":"J. Virol."},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1186\/1758-3284-1-7","article-title":"Gene therapy: the end of the rainbow","volume":"1","author":"Shillitoe","year":"2009","journal-title":"Head Neck Oncol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yebeh.2013.09.013","article-title":"Gene therapy for epilepsy","volume":"38","author":"Simonato","year":"2014","journal-title":"Epilepsy Behav."},{"key":"B193","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","article-title":"Progress in gene therapy for neurological disorders","volume":"9","author":"Simonato","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0166-2236(99)01539-8","article-title":"Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors","volume":"23","author":"Simonato","year":"2000","journal-title":"Trends Neurosci."},{"key":"B195","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.gt.3300479","article-title":"Interaction of vesicular stomatitis virus-G pseudotyped retrovirus with CD34+ and CD34+ CD38- hematopoietic progenitor cells","volume":"4","author":"Sinclair","year":"1997","journal-title":"Gene Ther."},{"key":"B196","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1006\/mthe.2000.0215","article-title":"Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression","volume":"2","author":"Smith-Arica","year":"2000","journal-title":"Mol. Ther."},{"key":"B197","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3171\/2010.4.PEDS09507","article-title":"Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations","volume":"6","author":"Souweidane","year":"2010","journal-title":"J. Neurosurg. Pediatr."},{"key":"B198","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-neuro-071013-014048","article-title":"Chemogenetic tools to interrogate brain functions","volume":"37","author":"Sternson","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"B199","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0021-9258(18)52392-9","article-title":"Allele-specific activation of genetically engineered receptors","volume":"266","author":"Strader","year":"1991","journal-title":"J. Biol. Chem."},{"key":"B200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1201\/9780203711828","volume-title":"Herpes simplex viruses","author":"Studahl","year":"2017"},{"key":"B201","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1128\/JVI.73.5.3649-3660.1999","article-title":"Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent","volume":"73","author":"Sutton","year":"1999","journal-title":"J. Virol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1128\/JVI.80.7.3293-3300.2006","article-title":"Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin","volume":"80","author":"Suzuki","year":"2006","journal-title":"J. Virol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B204","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1089\/hum.2013.238","article-title":"Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIA disease: results of a phase I\/II trial","volume":"25","author":"Tardieu","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.celrep.2015.10.061","article-title":"Activity of raphe serotonergic neurons controls emotional behaviors","volume":"13","author":"Teissier","year":"2015","journal-title":"Cell Rep."},{"key":"B206","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1113\/expphysiol.2004.028191","article-title":"Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function","volume":"90","author":"Teschemacher","year":"2005","journal-title":"Exp. Physiol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"B208","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/hum.2008.018","article-title":"An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector","volume":"20","author":"Tian","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"B209","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4161\/cam.2.3.6353","article-title":"\u201cArmed\u201d oncolytic herpes simplex viruses for brain tumor therapy","volume":"2","author":"Todo","year":"2008","journal-title":"Cell Adh. Migr."},{"key":"B210","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/emmm.201302948","article-title":"Effective delivery of large genes to the retina by dual AAV vectors","volume":"6","author":"Trapani","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/npp.2015.293","article-title":"Elucidation of The behavioral program and neuronal network encoded by dorsal raphe serotonergic neurons","volume":"41","author":"Urban","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B212","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1182\/blood-2002-07-2224","article-title":"IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes","volume":"101","author":"Verhoeyen","year":"2003","journal-title":"Blood"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41598-017-01635-1","article-title":"Engineered HSV vector achieves safe long-term transgene expression in the central nervous system","volume":"7","author":"Verlengia","year":"2017","journal-title":"Sci. Rep."},{"key":"B214","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/hum.2007.125","article-title":"Lentiviral vectors mediate nonimmunosuppressive rapamycin analog-induced production of secreted therapeutic factors in the brain: regulation at the level of transcription and exocytosis","volume":"19","author":"Vogel","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00013","article-title":"Recombinant human myelin-associated glycoprotein promoter drives selective AAV-mediated transgene expression in oligodendrocytes","volume":"9","author":"von Jonquieres","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065646","article-title":"Glial promoter selectivity following AAV-delivery to the immature brain","volume":"8","author":"von Jonquieres","year":"2013","journal-title":"PLoS One"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1099\/0022-1317-79-6-1461","article-title":"Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein","volume":"79","author":"Von Seggern","year":"1998","journal-title":"J. Gen. Virol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"13714","DOI":"10.1073\/pnas.240335297","article-title":"Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.gt.3302011","article-title":"Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain","volume":"10","author":"Wang","year":"2003","journal-title":"Gene Ther."},{"key":"B220","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1517\/17425247.2014.871258","article-title":"The potential of adeno-associated viral vectors for gene delivery to muscle tissue","volume":"11","author":"Wang","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"B221","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1525-0016(03)00094-7","article-title":"Single HSV-amplicon vector mediates drug-induced gene expression via dimerizer system","volume":"7","author":"Wang","year":"2003","journal-title":"Mol. Ther."},{"key":"B222","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/gad.954702","article-title":"Insulators: many functions, many mechanisms","volume":"16","author":"West","year":"2002","journal-title":"Genes Dev."},{"key":"B223","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.mt.6300326","article-title":"Breaking the bonds: Non-viral vectors become chemically dynamic","volume":"16","author":"Wolff","year":"2008","journal-title":"Mol. Ther."},{"key":"B224","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"B225","doi-asserted-by":"publisher","first-page":"17181","DOI":"10.1074\/jbc.M311683200","article-title":"Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B226","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1128\/JVI.70.9.6358-6369.1996","article-title":"Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22","volume":"70","author":"Wu","year":"1996","journal-title":"J. Virol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.1128\/JVI.00895-06","article-title":"Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1128\/JVI.80.1.27-37.2006","article-title":"Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses","volume":"80","author":"Xiong","year":"2006","journal-title":"J. Virol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1128\/JVI.79.1.364-379.2005","article-title":"Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes","volume":"79","author":"Yan","year":"2005","journal-title":"J. Virol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1073\/pnas.97.12.6716","article-title":"Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy","volume":"97","author":"Yan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/mt.2014.68","article-title":"Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10","volume":"22","author":"Yang","year":"2014","journal-title":"Mol. Ther."},{"key":"B232","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1093\/nar\/gkg742","article-title":"Retrovirus silencer blocking by the cHS4 insulator is CTCF independent","volume":"31","author":"Yao","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"B233","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1073\/pnas.91.20.9564","article-title":"A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes","volume":"91","author":"Yee","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B234","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/hum.1997.8.5-575","article-title":"Optimization of plasmid vectors for high-level expression in lung epithelial cells","volume":"8","author":"Yew","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"B235","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuron.2011.06.004","article-title":"Optogenetics in neural systems","volume":"71","author":"Yizhar","year":"2011","journal-title":"Neuron"},{"key":"B236","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000442891","article-title":"Optogenetic inhibition of the subthalamic nucleus reduces levodopa-induced dyskinesias in a rat model of Parkinson\u2019s disease","volume":"94","author":"Yoon","year":"2016","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"B237","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1227\/NEU.0000000000000297","article-title":"Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of Parkinson disease","volume":"74","author":"Yoon","year":"2014","journal-title":"Neurosurgery"},{"key":"B238","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1117\/12.2000480","article-title":"Optogenetics to target actin-mediated synaptic loss in Alzheimer\u2019s","volume":"8586","author":"Zahedi","year":"2013","journal-title":"Optogenetics: Optical Methods for Cellular Control"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1089\/104303403322124774","article-title":"Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes","volume":"14","author":"Zaupa","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"B240","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1073\/pnas.242738899","article-title":"Photochemical gating of heterologous ion channels: Remote control over genetically designated populations of neurons","volume":"100","author":"Zemelman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/mt.2010.132","article-title":"A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors","volume":"18","author":"Zhang","year":"2010","journal-title":"Mol. Ther."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/mt.2011.98","article-title":"Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."},{"key":"B243","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jconrel.2004.08.019","article-title":"Cationic compounds used in lipoplexes and polyplexes for gene delivery","volume":"100","author":"Zhang","year":"2004","journal-title":"J. Control. Release"},{"key":"B244","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1089\/hum.2017.049","article-title":"Gene therapy using a miniCEP290 fragment delays photoreceptor degeneration in a mouse model of Leber congenital amaurosis","volume":"29","author":"Zhang","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B245","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/JVI.70.10.7030-7038.1996","article-title":"Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted","volume":"70","author":"Zhou","year":"1996","journal-title":"J. Virol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/sj.gt.3302780","article-title":"Optimization of the Tet-On system for regulated gene expression through viral evolution","volume":"13","author":"Zhou","year":"2006","journal-title":"Gene Ther."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/npp.2014.35","article-title":"Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory","volume":"39","author":"Zhu","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B248","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nature16954","article-title":"A thalamic input to the nucleus accumbens mediates opiate dependence","volume":"530","author":"Zhu","year":"2016","journal-title":"Nature"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T21:50:08Z","timestamp":1610142608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":248,"alternative-id":["10.3389\/fphar.2019.00724"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00724","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"article-number":"724"}}